NCT00669565 - Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

August 31, 2010

Conditions

Carcinoma Breast Stage IV

Interventions

DRUG

Bavituximab

Receive weekly bavituximab at a dose of 3 mg/kg until disease progression, and carboplatin at a dose of AUC = 2 and paclitaxel 100 mg/m2 on days 1, 8, and 15 of a 28-day cycle for up to 6 cycles.

Trial Locations (9)

Unknown

Rajalakshmi Multispecialty Hospital, Bangalore

Bangalore Institute of Oncology, Banglore

Apollo Specialty Hospitals, Chennai

Nizam's Institute of Medical Sciences, Hyderabaad

Regional Cancer Center, Kerala

Medical College Hospital, Kolkata

Bharath Hospital and Institite of Oncology, Mysore

Curie Manavata Cancer Center, Nashik

Ruby Hall Clinic, Pune